DOP2002000325A - Antagonistas de receptores de histamina - Google Patents

Antagonistas de receptores de histamina

Info

Publication number
DOP2002000325A
DOP2002000325A DO2002000325A DO2002000325A DOP2002000325A DO P2002000325 A DOP2002000325 A DO P2002000325A DO 2002000325 A DO2002000325 A DO 2002000325A DO 2002000325 A DO2002000325 A DO 2002000325A DO P2002000325 A DOP2002000325 A DO P2002000325A
Authority
DO
Dominican Republic
Prior art keywords
histamine
receptor
receiver antagonists
histamine receiver
antagonists
Prior art date
Application number
DO2002000325A
Other languages
English (en)
Inventor
Stephen Jenkinson
Mark Anthony O Reilly
Michael Andrew Trevethick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DOP2002000325A publication Critical patent/DOP2002000325A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona una combinación de (a) Un antagonista de receptor H1 de histamina y (b) un antagonista que es al menos 10 veces más selectivo para el receptor H4 de histamina en comparación con el receptor H3 de histamina; y un antagonista que es al menos 10 veces más selectivo para el receptor H4 de histamina en comparación con el receptor H3 de histamina; y sus composiciones y usos.
DO2002000325A 2001-01-17 2002-01-11 Antagonistas de receptores de histamina DOP2002000325A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
DOP2002000325A true DOP2002000325A (es) 2003-01-31

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2002000325A DOP2002000325A (es) 2001-01-17 2002-01-11 Antagonistas de receptores de histamina

Country Status (31)

Country Link
EP (1) EP1353657A1 (es)
JP (1) JP2004517883A (es)
KR (1) KR20030069216A (es)
CN (1) CN1486178A (es)
AP (1) AP2002002401A0 (es)
AR (1) AR032101A1 (es)
BG (1) BG107834A (es)
BR (1) BR0206502A (es)
CA (1) CA2435121A1 (es)
CR (1) CR6983A (es)
CZ (1) CZ20031853A3 (es)
DO (1) DOP2002000325A (es)
EA (1) EA200300537A1 (es)
EC (1) ECSP034692A (es)
EE (1) EE200300335A (es)
GB (1) GB0101223D0 (es)
GT (1) GT200200003A (es)
HU (1) HUP0302767A2 (es)
IL (1) IL156087A0 (es)
IS (1) IS6818A (es)
MA (1) MA26980A1 (es)
MX (1) MXPA03006408A (es)
NO (1) NO20033223D0 (es)
OA (1) OA12440A (es)
PA (1) PA8537101A1 (es)
PL (1) PL362793A1 (es)
SK (1) SK8572003A3 (es)
SV (1) SV2003000849A (es)
TN (1) TNSN02003A1 (es)
WO (1) WO2002056871A2 (es)
ZA (1) ZA200304180B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
MXPA05002577A (es) * 2002-09-06 2005-09-20 Johnson & Johnson Uso de moduladores del receptor h4 de histamina para el tratamiento de alergia y asma.
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) * 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
HUE039713T2 (hu) 2012-06-08 2019-02-28 Sensorion H4 receptor inhibitorok tinnitus kezelésére

Also Published As

Publication number Publication date
NO20033223L (no) 2003-07-16
CN1486178A (zh) 2004-03-31
BR0206502A (pt) 2003-10-21
SV2003000849A (es) 2003-01-13
HUP0302767A2 (hu) 2003-11-28
CR6983A (es) 2003-11-25
GT200200003A (es) 2002-08-19
AR032101A1 (es) 2003-10-22
SK8572003A3 (en) 2004-07-07
MA26980A1 (fr) 2004-12-20
ZA200304180B (en) 2004-06-15
MXPA03006408A (es) 2003-10-15
PL362793A1 (en) 2004-11-02
OA12440A (en) 2006-05-22
EP1353657A1 (en) 2003-10-22
TNSN02003A1 (fr) 2005-12-23
WO2002056871A2 (en) 2002-07-25
IL156087A0 (en) 2003-12-23
NO20033223D0 (no) 2003-07-16
EA200300537A1 (ru) 2004-02-26
KR20030069216A (ko) 2003-08-25
IS6818A (is) 2003-05-15
BG107834A (bg) 2004-01-30
ECSP034692A (es) 2003-08-29
CA2435121A1 (en) 2002-07-25
AP2002002401A0 (en) 2002-03-31
PA8537101A1 (es) 2002-08-29
CZ20031853A3 (cs) 2004-07-14
EE200300335A (et) 2003-12-15
GB0101223D0 (en) 2001-02-28
JP2004517883A (ja) 2004-06-17

Similar Documents

Publication Publication Date Title
AU3652102A (en) Compounds and their uses
PA8567001A1 (es) Composicion de ziprasidona y controles sinteticos
DE60222396D1 (de) N-(2-arylethyl) benzylamine als 5-ht6 rezeptor-antagoniste
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
EA199900630A1 (ru) Антагонисты рецепторов витронектина
ECSP045274A (es) N-aminoacetil-pirrolidina-2-carbonitrilosy su uso como inhibidores ddp-iv
PT1305286E (pt) Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento
IL155236A0 (en) Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity
NO20032253D0 (no) Piperazinylpyrazinforbindelser som antagonister av serotonin 5-HT2-reseptorer
HN2002000299A (es) Derivados del 3- azabiciclo[3.1.0] hexano
UY27800A1 (es) Utilizacion de inhibidores de la transduccion de senales inducida por egfr para el tratamiento de la hiperplasia de la prostata benigna (hps) /hipertrofia de la prostata.
MXPA03010158A (es) Sulfonamidas.
DK1313485T3 (da) Anvendelse af en aldosteronreceptorantagonist til forbedring af kognitiv funktion
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
DE60132798D1 (de) Zusammensetzung einer natriumkanal-blockierenden verbindung
DOP2002000325A (es) Antagonistas de receptores de histamina
ECSP034558A (es) Moduladores del receptor estrogeno
PL1738106T3 (pl) Urządzenie do mieszania światła
UY27124A1 (es) Antagonistas de receptores de histamina
GT199900113A (es) Inhibidores de las fkbp.
PT1406888E (pt) Compostos de y-lactona substituida que servem como antagonistas de nmda
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
DK1420789T3 (da) Anvendelse af aktivstoffer med my-opioid-receptoragonistisk virkning og opioid-receptorantagonistisk virkning som kombinationslægemidler til cancerbehandling
ATE387201T1 (de) Pharmazeutische kombination von tenatoprazole und einem histamin-h2-rezeptor antagonisten
DE60220699D1 (de) Tibolonformulierungen